Predicted protein targets (top 20)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | PKM | P14618 | 2/20 | 0.87 |
| ▸ | PTGS1 | P23219 | 2/20 | 0.87 |
| ▸ | PTGS2 | P35354 | 2/20 | 0.87 |
| ▸ | KDM4E | B2RXH2 | 7/20 | 0.74 |
| ▸ | GAA | P10253 | 2/20 | 0.74 |
| ▸ | ALDH1A1 | P00352 | 4/20 | 0.70 |
| ▸ | HSD17B10 | Q99714 | 4/20 | 0.70 |
| ▸ | HPGD | P15428 | 3/20 | 0.70 |
| ▸ | HTR1A | P08908 | 1/20 | 0.70 |
| ▸ | HTR2C | P28335 | 1/20 | 0.70 |
| ▸ | CA12 | O43570 | 2/20 | 0.69 |
| ▸ | CA1 | P00915 | 2/20 | 0.69 |
| ▸ | CA2 | P00918 | 2/20 | 0.69 |
| ▸ | CA3 | P07451 | 2/20 | 0.69 |
| ▸ | CA4 | P22748 | 2/20 | 0.69 |
| ▸ | CA6 | P23280 | 2/20 | 0.69 |
| ▸ | CA5A | P35218 | 2/20 | 0.69 |
| ▸ | CA7 | P43166 | 2/20 | 0.69 |
| ▸ | CA9 | Q16790 | 2/20 | 0.69 |
| ▸ | CA14 | Q9ULX7 | 2/20 | 0.69 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL29537849 | 1.00 | PKM (0.87) | PKMPTGS1PTGS2KDM4EGAA | |
| SCHEMBL10085810 | 1.00 | PKM (0.87) | PKMPTGS1PTGS2KDM4EGAA | |
| Sinapinate SCHEMBL15515158 | 0.93 | PKM (1.00) | PKMPTGS1PTGS2KDM4EGAA | |
| Sinapinate SCHEMBL37313 | 0.93 | PKM (1.00) | PKMPTGS1PTGS2KDM4EGAA | |
| Sinapinate SCHEMBL37312 | 0.93 | PKM (1.00) | PKMPTGS1PTGS2KDM4EGAA | |
| Sinapinate SCHEMBL27753908 | 0.93 | PKM (1.00) | PKMPTGS1PTGS2KDM4EGAA | |
| Sinapinate SCHEMBL28937494 | 0.91 | PKM (0.96) | PKMPTGS1PTGS2KDM4EGAA | |
| Caffeic Acid SCHEMBL7527406 | 0.91 | KDM4E (0.76) | PKMPTGS1PTGS2KDM4EGAA | |
| SCHEMBL25308319 | 0.89 | PKM (0.69) | PKMPTGS1PTGS2KDM4EGAA | |
| SCHEMBL22555964 | 0.89 | ALOX5 (0.80) | PKMPTGS1PTGS2KDM4EGAA |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 730 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| CN-122005693-A | Application of Jiaweidanzhi Xiaoyao powder or extract thereof in preparation of medicines for treating depression complicated with ulcerative colitis | 河南中医药大学 | 2026-05-12 | — | — | CN | claimed |
| EP-4601608-A1 | ANTIPERSPIRANT COMPOSITIONS | Elementis Specialties, Inc. (US) | 2025-08-20 | — | — | EP | claimed |
| US-20250073143-A1 | PERSONAL CARE COMPOSITIONS INCLUDING ANTIPERSPIRANT, DEODORANT, AND ASTRINGENT COMPOSITIONS | ELEMENTIS SPECIALTIES INC (US) | 2025-03-06 | — | — | US | claimed |
| CN-119317673-A | Porous coating comprising minerals and oxygen scavengers for improving food shelf life | OMYA国际股份公司 | 2025-01-14 | — | — | CN | claimed |
| CN-118924839-B | Method for extracting and purifying allium mongolicum regel polyphenol with high biological activity | 内蒙古大学 | 2025-01-10 | — | — | CN | claimed |
| US-20240398677-A1 | ANTIPERSPIRANT COMPOSITIONS | ELEMENTIS SPECIALTIES, INC. (US) | 2024-12-05 | — | — | US | claimed |
| WO-2024249514-A1 | ANTIPERSPIRANT COMPOSITIONS | ELEMENTIS SPECIALTIES, INC. (US) | 2024-12-05 | — | — | WO | claimed |
| US-12076316-B2 | Levorphanol prodrugs and processes for making and using them | ZEVRA THERAPEUTICS INC. | 2024-09-03 | — | — | US | claimed |
| EP-3645492-B1 | PREPARATION PROCESS OF ORTHO ALKOXY BISPHENOL MONOMERS | UNIV LEUVEN KATH (BE) | 2024-08-21 | — | — | EP | claimed |
| CN-117554550-B | Liquid chromatography tandem mass spectrometry detection method for catecholamine metabolites in plasma and combined stabilizer | 大连博源医学科技有限公司 | 2024-06-04 | — | — | CN | claimed |
| CN-101448395-A | Compositions and methods for increasing the value of plant products, enhancing their commercial quality, enhancing their resistance to external agents and increasing their polyphenol content | ANTONI LESCHOT SANHUEZA ANDRES (CL) | 2009-06-03 | — | — | CN | claimed |
| EP-2003968-A2 | COMPOSITIONS AND METHODS TO ADD VALUE TO PLANT PRODUCTS, SO INCREASING THE COMMERCIAL QUALITY, RESISTANCE TO EXTERNAL FACTORS AND POLYPHENOL CONTENT THEREOF | Leschot Sanhueza, Andres Antonio (CL) | 2008-12-24 | — | — | EP | claimed |
| US-20080166731-A1 | Plant caffeic acid-3-O-methytransferase homologs | CAHOON REBECCA E | 2008-07-10 | — | — | US | claimed |
| US-20080166754-A1 | Plant caffeic acid-3-O-methyltransferase homologs | CAHOON REBECCA E | 2008-07-10 | — | — | US | claimed |
| US-20070232495-A1 | Compositions and methods to add value to plant products, increasing the commercial quality, resistance to external factors and polyphenol content thereof | NAPPA ALVARO O | 2007-10-04 | — | — | US | claimed |
| WO-2007110801-A2 | COMPOSITIONS AND METHODS TO ADD VALUE TO PLANT PORDUCTS, INCREASING THE COMMERCIAL QUALITY, RESISTANCE TO EXTERNAL FACTORS AND POLYPHENOL CONTENT THEREOF | LESCHOT SANHUEZA ANDRES ANTONI (CL) | 2007-10-04 | — | — | WO | claimed |
| US-20040014116-A1 | Plant caffeic acid 3-0-methyltransferase homologs | E.I. DU PONT DE NEMOURS AND COMPANY | 2004-01-22 | — | — | US | claimed |
| US-20020026658-A1 | Genes encoding sinapoylglucose: malate sinapoyltransferase and methods of use | CHAPPLE CLINTON C S (US) | 2002-02-28 | — | — | US | claimed |
| WO-2002004614-A2 | GENES ENCODING SINAPOYLGLUCOSE: MALATE SINAPOYLTRANSFERASE AND METHODS OF USE | PURDUE RESEARCH FOUNDATION (US) | 2002-01-17 | — | — | WO | claimed |
| US-4241536-A | Embryogenesis in vitro, induction of qualitative and quantitative changes in metabolites produced by plants and products thereof | SAINT FIRMIN ANNETTE R | 1980-12-30 | — | — | US | claimed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (4 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20070232495-A1 | Compositions and methods to add value to plant products, increasing the commercial quality, resistance to external factors and polyphenol content thereof | C5, PNN, NQO1 | PKM 2114/4885PTGS1 1945/4885PTGS2 1551/4885 |
| US-12076316-B2 | Levorphanol prodrugs and processes for making and using them | OPRM1, OPRL1, OPRK1 | PKM 2873/4885PTGS1 885/4885PTGS2 1209/4885 |
| US-20240398677-A1 | ANTIPERSPIRANT COMPOSITIONS | FABP6, PON1, CYP2A6 | PKM 3622/4885PTGS1 229/4885PTGS2 503/4885 |
| US-20250073143-A1 | PERSONAL CARE COMPOSITIONS INCLUDING ANTIPERSPIRANT, DEODORANT, AND ASTRINGENT COMPOSITIONS | CUTA, DEK, PPARG | PKM 3734/4885PTGS1 2287/4885PTGS2 3086/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.